Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Knee

NCT00504127 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1020

Last updated 2011-06-17

No results posted yet for this study

Summary

To study of efficacy and safety of Naproxcinod vs. Naproxen and Placebo in the indication of signs and symptoms of osteoarthritis

Conditions

Interventions

DRUG

Naproxcinod 375 mg bid

Naproxcinod 375 mg bid

DRUG

Naproxcinod 750 mg bid

Naproxcinod 750 mg bid

DRUG

Naproxen 500 mg bid

Naproxen 500 mg bid

DRUG

placebo

placebo

Sponsors & Collaborators

  • NicOx

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00504127 on ClinicalTrials.gov